J&J to acquire Cougar

Johnson & Johnson (NYSE:JNJ) said late Thursday that it plans to acquire Cougar Biotechnology Inc. (NASDAQ:CGRB) in a tender offer of $43 per share, or about $1 billion in cash. The price is a 16% pre...